UROGEN PHARMA LTD shareholders Q3 2023

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
Annandale Capital, LLC 81,831$1,1460.28%
RTW INVESTMENTS, LP 857,464$12,013,0710.25%
Harel Insurance Investments & Financial Services Ltd. 870,194$12,1910.24%
Migdal Insurance & Financial Holdings Ltd. 648,302$9,0830.19%
SHIKIAR ASSET MANAGEMENT INC 33,250$4660.16%
Coastal Bridge Advisors, LLC 38,500$539,3850.14%
BENDER ROBERT & ASSOCIATES 34,701$486,1610.14%
Vivaldi Capital Management LP 16,461$230,6190.08%
DENALI ADVISORS LLC 14,300$200,3430.07%
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD 21,823$314,2180.07%
External links

This page lists UROGEN PHARMA LTD's shareholders in Q3 2023. To view UROGEN PHARMA LTD's shareholder history, click here.